GHRH and breast carcinoma: In breast cancer lines, the stimulated level of rhGH (551.1 pg/ml) was reduced by 88.2±11.4% (p < 0.05) in the presence of MR-409 and by 70.4±14.2% (p < 0.05) after exposure to GHRH(1-29)NH2.